Gonorrhoea is becoming more resistant to antibiotics Resistance to antibiotics used to treat gonorrhoea is increasing in England and Wales, according to figures published in the 2013 Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) report.…
Ebola research gets a 280m euro boost from EU and drug industry The European Union has pledged 280m euro to a research project to develop vaccines and diagnostic tests for Ebola.…
Public Health England reminds prescribers of effectiveness of antivirals for fluDoctors have been instructed to prescribe antivirals for patients with severe influenza and not to be swayed by data showing that these drugs may not be effective.…
Call for NHS to reduce antibiotic use to 2010 levels NHS must commit to national targets to use fewer antibiotics to halt the rise in antimicrobial resistance, according to a coalition of health professional bodies.…
Improving antimicrobial stewardship Improve your practice and slow the increasing levels of antimicrobial resistance that already cost around 25,000 deaths across Europe each year.…
Q&A: Ensuring vaccine safety is no easy task Patrick LF Zuber, group leader for global vaccine safety at the World Health Organization, talks about vaccine safety, the Ebola vaccine and new vaccines in the pipeline.…
Medicines regulator reviews chloramphenicol packaging after picking errors Regulators are working with community pharmacy organisations to review the packaging of chloramphenicol eye and ear drops.…
Chemical screening unearths tannic acid as candidate for cystic fibrosis therapy Researchers have found that tannic acid is able to act against Staphylococcus aureus, a major cause of infection in cystic fibrosis.…
Vaccine for human respiratory syncytial virus on the horizonA vaccine being developed to protect against human respiratory syncytial virus may offer hope in preventing this major cause of infant infection.…
Boosting drugs manufacture in developing countries will improve health outcomes, UN investment forum told Increasing pharmaceutical production in developing countries — especially in sub-Saharan Africa — could improve access to affordable medicines, experts say. …